Influence of ursodeoxycholic acid on insulin resistance in patients with metabolic syndrome

The lecture describes the mechanisms of non-alcoholic fatty liver disease in patients with metabolic syndrome. A comprehensive treatment with the use of ursodeoxycholic acid has reduced the severity of hepatic steatosis, manifestations of dyslipidemia, the syndromes of cytolysis and cholestasis, the...

Full description

Bibliographic Details
Main Author: V.I. Pankiv
Format: Article
Language:English
Published: Publishing House Zaslavsky 2018-04-01
Series:Mìžnarodnij Endokrinologìčnij Žurnal
Subjects:
Online Access:http://iej.zaslavsky.com.ua/article/view/136424